Neurorehabilitation Devices Market Growth: Rising Demand Driven by Neurological Disorders

The neurorehabilitation devices market was valued at USD 2.25 billion in 2024 and is projected to reach USD 7.15 billion by 2033, expanding at a CAGR of 13.7% (2025–2033). Growth is fueled by the rising burden of neurological disorders and a rapidly aging global population.

📥 Download Sample

Key Market Insights

North America dominated the industry with a 40% share in 2024
The neurorobotics segment led the product category with 45% share in 2024
The stroke application segment is growing at a 12% CAGR
Hospitals and clinics remain the largest end-users of neurorehabilitation devices

Market Growth Drivers

Increasing Prevalence of Neurological Disorders

Neurological illnesses such as migraine, dementia, Alzheimer's disease, epilepsy, and brain tumors affect nearly 1 billion people globally, according to WHO. These conditions are the second leading cause of death, contributing to 9 million deaths annually. Rising cases of dementia, with nearly 50 million people worldwide affected and 10 million new cases annually, further push the demand for neurorehabilitation solutions.

Expanding Geriatric Population

As per the United Nations, the global population aged 65 and above reached 771 million in 2022 (10% of the total population) and is expected to rise to 16% by 2050. Since neurological conditions like Alzheimer's are more common among older adults, the growing geriatric population is a major factor driving demand for neurorehabilitation devices.

Market Challenges

A shortage of skilled technical experts remains a key restraint. According to McKinsey Global Institute, the EU public sector alone faces a skills deficit of 8.6 million people in tech and healthcare-related fields. Developing economies, in particular, struggle to adopt advanced neurorehabilitation technologies due to limited expertise and resources.

Opportunities Ahead

Technological advancements are creating new opportunities. For example, Flint Rehab launched MiGo, a wearable activity tracker for stroke survivors, while BeAble Health introduced ArmAble, a gamified rehabilitation device for stroke and neurological conditions. Such innovations are making rehabilitation more engaging, personalized, and accessible.

Regional Insights

North America

North America leads the market due to a high prevalence of neurological disorders, favorable government initiatives, and strong funding for R&D. The FDA’s approval of the Neurolutions IpsiHand System in 2021 and investments like Neurofenix’s EUR 7 million funding in 2022 highlight the region’s strong innovation ecosystem.

Europe

Europe faces a high prevalence of dementia, with nearly 7.8 million people affected in the EU. By 2050, this number is expected to nearly double. With 21.1% of the EU population aged 65 or older in 2022, the region presents significant opportunities for device adoption.

Asia-Pacific

Countries like China and India are witnessing rising demand for neurorehabilitation due to increasing clinical trials, improving healthcare infrastructure, and growing disposable incomes. For instance, Lupin launched Atharv Ability, an advanced neuro-rehabilitation facility in Mumbai in 2023, boosting access to state-of-the-art rehabilitation services.

Market Segmentation

By Product: Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Others
By Application: Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Others
By End-User: Rehabilitation Centers, Hospitals and Clinics, Home Care, Others
By Region: North America, Europe, Asia-Pacific, Middle East & Africa, Latin America

Key Players in the Neurorehabilitation Devices Market

Bioventus
Ectron
Hocoma
Tyromotion Inc.
Biometrics Ltd.
DIH
Medtronic
Bionik Laboratories Corp.
BioXtreme Ltd.
Kinestica
Kinova Inc.
Ekso Bionics
Neuro Rehab VR
Saebo, Inc.
Abbott

Recent Developments

October 2023: MedRhythms launched InTandem, a prescription-only neurorehabilitation system for stroke patients with chronic walking impairments.
August 2023: ReWalk Robotics acquired AlterG, a leader in anti-gravity systems for neurological rehabilitation.

About Us

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.